-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GxH8GnXaeI9NIbg/w897B/0oy7QG0zDo1MbC5PIxUL3TmTpSzqOw+ZJaxm/hzWRc vSKTuL/x35NBG6w/RaW/IQ== 0001273547-06-000001.txt : 20060418 0001273547-06-000001.hdr.sgml : 20060418 20060418155451 ACCESSION NUMBER: 0001273547-06-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060414 FILED AS OF DATE: 20060418 DATE AS OF CHANGE: 20060418 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUNY PARK SCIENCE III STREET 2: SUITE 144 CITY: BINGHAMTON STATE: NY ZIP: 13902-6000 BUSINESS PHONE: 6077772775 MAIL ADDRESS: STREET 1: SUNYPARK SCIENCE III STREET 2: STE 144 CITY: BINGHAMTON STATE: NY ZIP: 13902-6000 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIRSCHWEILER THOMAS CENTRAL INDEX KEY: 0001273547 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18170 FILM NUMBER: 06764833 BUSINESS ADDRESS: STREET 1: BIOLIFE SOLUTIONS INC STREET 2: SCIENCE 3 STE 144 SUNY PARK CITY: BINGHAMTON STATE: NY ZIP: 13902 BUSINESS PHONE: 6077772801 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-04-14 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001273547 GIRSCHWEILER THOMAS C/O BIOLIFE SOLUTIONS, INC. 171 FRONT STREET OWEGO NY 13827 1 0 0 0 Common Stock 2006-04-14 4 M 0 250000 .04 A 12698000 D Common Stock 2006-04-14 4 X 0 690000 .04 A 12698060 D Common Stock 2006-04-14 4 X 0 3125000 .04 A 12698060 D Common Stock 2006-04-14 4 X 0 240000 .04 A 12698060 D Common Stock 2006-04-14 4 X 0 1000000 .04 A 12698060 D Common Stock 2006-04-14 4 X 0 400000 .04 A 12698060 D Common Stock 2006-04-14 4 X 0 500000 .04 A 12698060 D Common Stock 2006-04-14 4 X 0 500000 .04 A 12698060 D Common Stock 2006-04-14 4 C 0 1380000 .25 A 12698060 D Common Stock 2006-04-14 4 C 0 3125000 .08 A 12698060 D Stock Option (right to buy) .04 2006-04-14 4 M 0 250000 0 D 2005-09-28 2015-09-28 Common Stock 250000 0 D Warrant (right to buy) .04 2006-04-14 4 X 0 690000 D 2001-10-10 2006-10-10 Common Stock 690000 0 D Warrant (right to buy) .04 2006-04-14 4 X 0 3125000 D 2003-11-20 2013-11-20 Common Stock 3125000 0 D Warrant (right to buy) .04 2006-04-14 4 X 0 240000 D 2001-10-16 2006-10-16 Common Stock 240000 0 D Warrant (right to buy) .04 2006-04-14 4 X 0 1000000 D 2002-03-19 2007-03-19 Common Stock 1000000 0 D Warrant (right to buy) .04 2006-04-14 4 X 0 400000 D 2002-05-10 2007-05-10 Common Stock 400000 0 D Warrant (right to buy) .04 2006-04-14 4 X 0 500000 D 2003-03-29 2008-03-29 Common Stock 500000 0 D Warrant (right to buy) .04 2006-04-14 4 X 0 500000 D 2003-05-02 2008-05-02 Common Stock 500000 0 D Series F Convertible Preferred Stock 2006-04-14 4 C 0 3450 D Common Stock 1380000 0 D Series G Convertible Preferred Stock 2006-04-14 4 C 0 10 D Common Stock 3125000 0 D In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the option from 3/23/2006 thorugh 4/14/2006 at $.04 per share. The exercise price of the option was $.08 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the warrant from 3/23/2006 thorugh 4/14/2006 at $.04 per share. The exercise price of the warrant was $.375 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the warrant from 3/23/2006 thorugh 4/14/2006 at $.04 per share. The exercise price of the warrant was $.08 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the owarrant from 3/23/2006 thorugh 4/14/2006 at $.04 per share. The exercise price of the warrant was $.375 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the warrant from 3/23/2006 thorugh 4/14/2006 at $.04 per share. The exercise price of the warrant was $.08 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the warrant from 3/23/2006 thorugh 4/14/2006 at $.04 per share. The exercise price of the warrant was $.25 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the warrant from 3/23/2006 thorugh 4/14/2006 at $.04 per share. The exercise price of the warrant was $.08 per share. In connection with an offer made by the Company to the holders of all outstanding vested warrants/options of the Company, the reporting person was given the right to exercise the warrant from 3/23/2006 thorugh 4/14/2006 at $.04 per share. The exercise price of the warrant was $.08 per share. The Series F Convertible Preferred Stock was convertible into 400 shares of common stock at any time, and had no expiration date. The Series G Convertible Preferred Stock was convertible into 312,500 shares of common stock at any time, and had no expiration date. Thomas Girschweiler 2006-04-14 -----END PRIVACY-ENHANCED MESSAGE-----